Perspective Therapeutics, Inc.
CATX
$1.92
-$0.02-1.03%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -62.79% | -46.02% | -5.38% | -3,211.05% | -655.28% |
| Total Depreciation and Amortization | 5,526.92% | 140.65% | 117.49% | 78.89% | -136.11% |
| Total Amortization of Deferred Charges | 0.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 84.22% | 134.72% | -54.19% | 104.17% | 3,646.02% |
| Change in Net Operating Assets | -557.48% | 2,588.89% | 28.62% | 5,845.70% | 268.46% |
| Cash from Operations | -195.36% | 133.29% | -10.28% | 242.43% | -108.37% |
| Capital Expenditure | -16,320.22% | -12,989.43% | -82.88% | -4,413.43% | -45.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -12,566.67% | -267.92% | -100.00% |
| Cash from Investing | -155,632.58% | -13,000.00% | -475.04% | -287.23% | -101.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 23.81% | 60.00% | 20.00% | -- |
| Issuance of Common Stock | -- | 2,827.27% | 22,849.62% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.99% | 62,700.00% | 23,744.53% | 208,010.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,785.23% | -149.06% | 1,451.13% | 759.56% | -536.38% |